Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder

OBJECTIVE: Our aim was to determine whether serum C-X-C motif chemokine 5 (CXCL5) may serve as a diagnostic biomarker for relapsing-remitting multiple sclerosis (RRMS) as well as a marker that can be used to predict treatment response. METHODS: CXCL5 levels were measured by ELISA in sera of 20 RRMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaaslan, Zerrin, Yilmaz, Vuslat, Yuceer, Hande, Sanli, Elif, Akcay, Halil Ibrahim, Kurtuncu, Murat, Turkoglu, Recai, Tuzun, Erdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331241/
https://www.ncbi.nlm.nih.gov/pubmed/37435281
http://dx.doi.org/10.14744/nci.2022.77861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331241/
https://www.ncbi.nlm.nih.gov/pubmed/37435281
http://dx.doi.org/10.14744/nci.2022.77861

Ejemplares similares